Bio & Pharma
Bio & Pharma
GC Biopharma breaks ground on blood product plant in Indonesia
Dec 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanwha to re-enter biopharma market, targeting biomaterials
South Korea’s Hanwha Group will re-enter the biopharmaceutical market to become the country’s sole producer of tris buffers, a key reage...
Dec 05, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Access Bio opens second plant in New Jersey
The US-based in-vitro diagnostic device company Access Bio Inc. announced on Monday that it opened its second factory in Monroe Township, New Jersey...
Dec 04, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Lunit selected as contractor for building medical AI platform in Singapore
South Korean medical AI company Lunit announced on Friday that it has been selected as the final contractor in the bidding for the establishment of ...
Dec 01, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Daewoong Pharm set to export Envlo Tab to Russia, CIS
Daewoong Pharmaceutical, a leading South Korean pharmaceutical company will export its new diabetes drug Envlo Tab. (active ingredient:enavogliflozi...
Dec 01, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion Healthcare's Remsima SC to be launched in US in 2024
Celltrion Healthcare Co. announced on Thursday that its autoimmune disease treatment Zymfentra (the US product name for Remsima SC) is set to be lau...
Nov 30, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
JW Holdings starts to export Winuf to Mongolia
South Korea's JW Holdings corporation announced on Tuesday that it started to export the multi-nutritional liquid Winuf Central 736·1085ml to...
Nov 28, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Biologics reaches record-breaking annual orders
Samsung Biologics Co., the world’s top contract manufacturing organization (CMO) by capacity, surpassed the annual contract manufacturing orde...
Nov 28, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Korea to invest $200 mn in new drugs, vaccines by 2028
South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...
Nov 24, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
GC Biopharma wins $10 mn order for flu vaccine in Thailand
South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...
Nov 23, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK C&C to promote AI healthcare for brain diseases
South Korea's SK C&C announced on Thursday that it signed a strategic business agreement with Neurophet, a cloud-based AI platform for brain ima...
Nov 23, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
KAIST, IVI to collaborate on global vaccine research
The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...
Nov 23, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK Pharmteco launches new viral vector platforms, key for CGT
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has recently introduced two...
Nov 22, 2023 (Gmt+09:00)
4 Min read -
Bio & Pharma
SK Bioscience to develop 2nd-generation Ebola vaccine
South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...
Nov 22, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Cytogen, Japan NCCH collaborate on cancer research
South Korea's Cytogen, Inc. announced on Monday it will start cancer research using circulating tumor cells (CTC) with the National Cancer Center Ho...
Nov 20, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Med. Center achieves Korea's first uterine transplantation
The first successful case of uterine transplantation surgery in Korea has been reported, with the patient currently preparing for pregnancy. Samsung...
Nov 17, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK Biopharm gears up to boost epilepsy drug sales in Europe
SK Biopharmaceuticals Co. is gearing up to explore the European market for its flagship epilepsy drug Cenobamate, while looking for new mergers and ...
Nov 16, 2023 (Gmt+09:00)
long read -
Bio & Pharma
South Korean bio, pharma industry set to take leap
South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...
Nov 15, 2023 (Gmt+09:00)
3 Min read -
Bio & Pharma
'World-class bispecific antibody technology of ABL Bio'
MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...
Nov 13, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Celltrion to supply Remsima to Brazil gov’t in three-year row
South Korea's Celltrion Healthcare Co. announced on Friday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for the B...
Nov 10, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Lunit participates in US gov't Cancer Moonshot
South Korea's medical AI company Lunit announced on Friday it will participate in the US President Joe Biden's cancer-conquering project Cancer Moon...
Nov 10, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK Biopharma’s Cenobamate US patent extended by 2032
South Korea's SK Biopharmaceuticals announced on Friday an extension of its US patent for the epilepsy treatment Cenobamate, now set to expire on Oc...
Nov 10, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
JLK supplies AI stroke solutions to Philippines
JLK Inc., South Korea's stroke diagnosis specialist company, announced on Thursday it implemented two artificial intelligence (AI) stroke diagnostic...
Nov 09, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Doctornow signs business agreement with Spain’s Mediktor
South Korea's medical care startup Doctornow Inc. announced on Wednesday it signed a strategic business agreement with global artificial intelligenc...
Nov 08, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Gencurix gets FDA OK for breast cancer prognosis analysis device
South Korean biotech company Gencurix Inc. announced on Wednesday its subsidiary GenoBio has received approval from the US Food and Drug Admini...
Nov 08, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Chong Kun Dang rallies on $1.3 bn deal with Novartis
Chong Kun Dang Pharmaceutical Corp.'s shares zoomed more than 25% on Monday on news that the South Korean medicine developer has signed its biggest-...
Nov 06, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Dong-A ST, UMass to jointly research for gene therapy
South Korea's Dong-A ST announced on Friday it has signed a joint research agreement with the University of Massachusetts (UMass) Chan Medical Schoo...
Nov 03, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Naver-invested ichrogene enters Thai market
South Korea's digital healthcare startup ichrogene, with investment from Naver D2 Startup Factory (D2SF), entered into Thai market. Naver Corp....
Nov 01, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Engineering secures $349 mn bio plant deal
South Korea's Samsung Engineering secured a deal for the Songdo Bio Raw Material Plant construction project from the global life sciences and labora...
Nov 01, 2023 (Gmt+09:00)
1 Min read
Latest News
- 1 BMW Surpasses Mercedes in Sales – Imported Car Market 'Shake-Up'
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google